p53, a Novel Inhibitor of Apoptosis
Author(s)
Chee, Lai Yuen
Type
Thesis or dissertation
Abstract
p53 is a transcription factor known to induce apoptosis via transactivating the expression of pro-apoptotic proteins and by directly activating the mitochondria apoptotic pathway. p53 is also found to be mutated in 50% of human cancers with some of these tumours overexpressing both wild type (WT) and mutant p53. Overexpression of the p53 protein has been implicated with the more aggressive nature of these tumour cells, suggesting a possible gain-of-function of such mutants. In this study, the involvement of p53 in apoptosis via the caspase pathway was investigated. WT-p53 and three mutant p53 with mutations at the 1) N-terminus (D42Y), 2) central domain (R175H) and 3) C-terminus (R337H) were selected. The data collected demonstrated that p53 was able to inhibit the cleavage of caspases early in the apoptotic pathway. In vitro assays showed that addition of recombinant WT and the mutant p53 inhibited the cleavage of both caspase-9 and caspase-3 and subsequently PARP, while overexpression of p53 in mammalian cells yielded the same inhibition profile in vivo. Conversely, removal of p53 via siRNA and immunodepletetion showed accelerated caspase-9 activity and cleavage. Immunoprecipitation experiments and recombinant assay systems suggest that the inhibition by p53 is targeted at the active cleaved caspase-9. In addition, the presence of p53 (WT or mutant) in p53-null cells were able to confer a higher survival rate. These data therefore demonstrate that p53 may have an additional anti-apoptotic role via the inhibition of caspase-9, which is often masked by its pro-apoptotic functions. This anti-apoptotic role could manifest itself in a cancer background overexpressing mutant p53 which has lost its transcriptional activity and hence its ability to induce apoptosis via the induction of pro-apoptotic genes such as PUMA and NOXA. This newly discovered role of p53 could potentially explain the aggressive nature of cancers which overexpress p53.
Date Issued
2011
Date Awarded
2011-04
Advisor
Gabra, Hani
Meng, Lim Tit
Lane, David
Creator
Chee, Lai Yuen
Publisher Department
Medicine: Department of Surgery and Cancer
Publisher Institution
Imperial College London
Qualification Level
Doctoral
Qualification Name
Doctor of Philosophy (PhD)